Get the Stockscreener App
31.98
1.87%
-0.6101
After Hours:
31.97
-0.01
-0.03%
Roundhill Glp 1 Weight Loss Etf stock is traded at $31.98, with a volume of 106.18K.
It is down -1.87% in the last 24 hours and down -4.96% over the past month.
See More
Previous Close:
$32.59
Open:
$32.49
24h Volume:
106.18K
Relative Volume:
4.70
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.54%
1M Performance:
-4.96%
6M Performance:
-1.02%
1Y Performance:
+22.65%
1-Day Range:
$31.97
$32.52
1-Week Range:
$31.97
$33.69
52-Week Range:
$25.66
$37.15
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Name
Roundhill Glp 1 Weight Loss Etf
Sector
Industry
Phone
-
Address
-
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
31.98 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
375.56 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
762.40 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
766.10 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
294.09 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
716.35 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Latest News
OZEM Top Holdings List & Exposure (Roundhill GLP-1 & Weight Loss ETF) - MarketBeat
Precision Trading with Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Risk Zones - Stock Traders Daily
How to Buy Novo Nordisk Stock (NVO): Step-by-Step & What to Expect - The Motley Fool
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Structure Therapeutics Inc (GPCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viking Therapeutics Inc (VKTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OZEM Dividend: 1.26% Yield, $0.41/Share — History & Dates - GuruFocus
OZEM ETF Profile: Dividends, Returns (BOATS:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (NASDAQ:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (CFI:OZEM) - TradingView
OZEM Archives - 24/7 Wall St.
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage - The Globe and Mail
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - The Globe and Mail
Biohaven Ltd (BHVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Metsera Inc (MTSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Terns Pharmaceuticals Inc (TERN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Trends
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - Yahoo Finance
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Financials Data
There is no financial data for Roundhill Glp 1 Weight Loss Etf (OZEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.50%
7.15%
Cap:
|
Volume (24h):